Evidence map›Paper›PMID 23771521›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2013

Grape seeds: ripe for cancer chemoprevention.

Santosh K Katiyar, Mohammad Athar

Open access · bronzeAbstract readComment
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Phytochemical Modulation of MiRNAs in Colorectal Cancer.Medicines (Basel, Switzerland) · 2019
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Kaempferol targets RSK2 and MSK1 to suppress UV radiation-induced skin cancer.Cancer prevention research (Philadelphia, Pa.) · 2014
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Santosh K KatiyarDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. skatiyar@uab.edu
Mohammad Athar
Birmingham VA Medical Center · USUniversity of Alabama at Birmingham · US

Funding

Inhibiting Multiple Molecular Targets for Preventing Non-Melanoma Skin CancerR01CA138998 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ATHAR, MOHAMMAD · 2011 to 2015
$1.5M
Proanthocyanidins,Novel bioactive components for prevention of melanoma invasionR21CA166883 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KATIYAR, SANTOSH KUMAR · 2013 to 2014
$346k
NCI NIH HHS CA166883NCI NIH HHS R01 CA138998NCI NIH HHS R21 CA166883
6 · The paper itself

Abstract

A wide variety of phytochemicals, mostly flavonoids or polyphenolics, have been shown to possess anticarcinogenic activities. Among these are the grape seed proanthocyanidins (GSPs), which are the active ingredients of grape seed extract (GSE). Substantial in vitro and preclinical in vivo studies have shown the chemopreventive efficacy of GSPs against various forms of cancers in different tumor models. In this issue of the journal, Derry and colleagues show that administration of GSE in the diet reduces azoxymethane-induced colon carcinogenesis in an A/J mouse model. The results of this innovative and comprehensive study indicate that inhibition of azoxymethane-induced colon cancer by dietary GSE is mediated through the induction of apoptosis that is associated with alterations in microRNA (miRNA) and cytokine expression profiles as well as β-catenin signaling. Notably, the demonstration that miRNA expression is affected by dietary GSE suggests a novel underlying mechanism for the chemopreventive action of GSE in colon cancer and, potentially, other cancers.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicAzoxymethaneCell Transformation, NeoplasticColonic NeoplasmsGrape Seed ExtractMaleMicroRNAsSignal TransductionAntineoplastic Agents, PhytogenicAzoxymethaneGrape Seed ExtractMicroRNAs

Identifiers

PMID23771521
PMCPMC3710656
OpenAlexW2119580706

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.